Company
Headquarters: Guangzhou, China
Employees: 32,337
CN¥15.80 Billion
CNY as of Jan. 1, 2025
US$2.16 Billion
Company | Market Cap (USD) |
---|---|
Novo Nordisk | $622.07 B |
Vertex Pharmaceuticals Incorporated | $113.24 B |
CSL Limited | $95.75 B |
Regeneron Pharmaceuticals, Inc. | $76.33 B |
Marinomed Biotech AG | $56.13 B |
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. The company was founded in 1999 and is based in Guangzhou, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Last Financial Reports Date | Sept. 30, 2024 |
Revenue TTM | CN¥26.54 B |
EBITDA | CN¥3.24 B |
Gross Profit TTM | CN¥9.01 B |
Profit Margin | 3.20% |
Operating Margin | 5.35% |
Quarterly Revenue Growth | 11.40% |
DaShenLin Pharmaceutical Group Co. Ltd has the following listings and related stock indices.
Stock: SSE: 603233 wb_incandescent